INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION

Información del proyecto

PhytoAPP

Identificador del acuerdo de subvención: 101007642

DOI

10.3030/101007642

Fecha de la firma de la CE 13 Octubre 2020

Fecha de inicio 1 Marzo 2021

Fecha de finalización 28 Febrero 2026

Financiado con arreglo a

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coste total

€ 883 200,00

Aportación de la UE

€ 883 200,00

Coordinado por

COFAC COOPERATIVA DE FORMACAO E ANIMACAO CULTURAL CRL
Portugal

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Other (6)

Summer School

Advance in Medical Science. It is planned. 8 lecturers, 30 participants. Duration 3 days.

Project Conference

Functional NMs for the Medical Application: Innovation and Challenges. It is planned 15 lecturers, 50 participants. Duration 3‑4 days.

3rd Workshop

Safety and Regulation of the Materials for the Medical Application. It is planned 5 lecturers, 30 participants.

Midterm meeting

Due to an extension Midterm with POREA will be aligned in 29 project month

1st Workshop

Innovative NMs for Medical Application It is planned Number 5 lecturers 15 participants

2nd Workshop

Engineering Design of Biobased Nanomaterials and NanoPharmaceuticals It is planned 5 lecturers 25 participants

Open Research Data Pilot (1)

Data Management Plan

Project Managament Plan will be prepared during first 6 months of the project summarising all the required knowledge for the good management of the project in terms of administrative forms financial aspects quality process etc

Documents, reports (6)

Dissemination and Communication Plans

Dissemination and Communication Plans will be worked out discussed and approved during the first meeting of consortium These plans will describe the Impact Maximization goals targets groups actions of the consortium and partners according to the appropriate time plan

PROTOCOL on in vitro Bioactivity Testing, NANOTOXICITY Assessment

Extended Bioactivity Testing: in vitro anti-viral, anti-oxidant; UV-protection of the PhytoAPP products Nanotoxicity assessment

Operation MECHANISM SIMULATION

Development ofthe original software to adress fibrilation mechanism

KINETICS of the Amyloid Fibril Formation in a presence of elaborated Phytomaterials

Extended studies on kinetics of amyloid fibrils formation with novel products

PROTOCOL on in vivo PRECLINICAL STUDY

Rodent models of neurodegenerative disease in vivo studies and Brain Blood Barrier permeability studies

Protocol in vitro testing anti COVID 19

To adress COVID-19 emergency add objective NEUROPLAST (NL) will perform anti-virus test of novel water-soluble antioxidant Phytoproducts

Publicaciones

Peer reviewed articles (5)

Understanding the Role of Oxidative Stress, Neuroinflammation and Abnormal Myelination in Excessive Aggression Associated with Depression: Recent Input from Mechanistic Studies

Autores: Anna Gorlova, Evgeniy Svirin, Dmitrii Pavlov, Raymond Cespuglio, Andrey Proshin, Careen A Schroeter, Klaus-Peter Lesch, Tatyana Strekalova
Publicado en: International Journal of Molecular Sciences, Edición 24, 2022, Página(s) 915, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms24020915

Distribution and inter-regional relationship of amyloid-beta plaque deposition in a 5xFAD mouse model of Alzheimer's disease

Autores: Ka Chun Tsui, Jaydeep Roy, Sze Chun Chau, Kah Hui Wong, Lei Shi, Chi Him Poon, Yingyi Wang, Tatyana Strekalova, Luca Aquili, Raymond Chuen-Chung Chang, Man-Lung Fung, You-Qiang Song, Lee Wei Lim
Publicado en: Frontiers Aging Neuroscience, Edición Jul 28;14:964336, 2022, Página(s) 964336, ISSN 1663-4365
Editor: Frontiers Research Foundation
DOI: 10.3389/fnagi.2022.964336

Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice.

Autores: Schapovalova O., Gorlova A., de Munter J., Sheveleva E., Eropkin M., Gorbunov N., Sicker M., Umriukhin A., Lyubchyk S., Lesch K-P., Strekalova T. and Schroeter C.A
Publicado en: Front. Med.,Sec. Translational Medicine, 2022, ISSN 2296-858X
Editor: Frontiers Media S.A.
DOI: 10.3389/fmed.2022.952977

In FUS[1-359]-tg mice O,S-dibenzoyl thiamine reduces muscle atrophy, decreases glycogen synthase kinase 3 beta, and normalizes the metabolome

Autores: Probert F, Gorlova A, Deikin A, Bettendorff L, Veniaminova E, Nedorubov A, Chaprov KD, Ivanova TA, Anthony DC, Strekalova T.
Publicado en: Biomedicine and Pharmacotherapy, Edición 2022 Dec;156:113986, 2022, Página(s) 113986, ISSN 1950-6007
Editor: Elsevier
DOI: 10.1016/j.biopha.2022.113986

Aberrant Ganglioside Functions to Underpin Dysregulated Myelination, Insulin Signalling, and Cytokine Expression: Is There a Link and a Room for Therapy?

Autores: Evgeniy Svirin, Johannes de Munter, Aleksei Umriukhin, Elisaveta Sheveleva, Allan V Kalueff, Andrei Svistunov, Sergey Morozov, Susanne Walitza, Tatyana Strekalova
Publicado en: Biomolecules, Edición Oct 7;12(10):1434, 2022, Página(s) 1434, ISSN 2218-273X
Editor: MDPI
DOI: 10.3390/biom12101434